Journal Article Summary

The article examines the use of topical finasteride as a treatment for androgenetic alopecia (AGA), a common condition that causes hair loss in both men and women. AGA can significantly affect individuals' self-esteem and quality of life, and current FDA-approved treatments are limited. While oral finasteride is effective, it can lead to side effects that discourage long-term use. This study aims to explore whether topical finasteride could provide a safer alternative with fewer systemic side effects.

The researchers conducted a systematic review of existing studies on topical finasteride, focusing on its efficacy and safety. They identified seven relevant studies involving a total of 256 participants, which included randomized controlled trials and prospective studies. The findings indicated that topical finasteride significantly reduced hair loss and increased hair counts without affecting serum testosterone levels. Overall, the results suggest that topical finasteride is a promising option for treating AGA, with a favorable safety profile compared to its oral counterpart.

Despite the encouraging results, the article notes several limitations, including the small number of studies and participants involved. There is a need for larger, more comprehensive studies to better understand the long-term effects and potential side effects of topical finasteride. Patients considering this treatment should discuss it with their healthcare provider, especially regarding the best application methods, potential side effects, and whether it is suitable for their specific situation.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Lee Sung Won, Juhasz Margit, Mobasher Pezhman, Ekelem Chloe, Mesinkovska Natasha Atanaskova. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women. Journal of drugs in dermatology : JDD 2018. PMID: 29601622. PMCID: PMC6609098.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]